Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

Thamir M. Alshammari, Wa’ad H. Al-Kathiri, Hervé Le Louet and Hisham S. Aljadhey
Saudi Medical Journal July 2015, 36 (7) 821-828; DOI: https://doi.org/10.15537/smj.2015.7.11751
Thamir M. Alshammari
From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France
MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Wa’ad H. Al-Kathiri
From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France
BSc, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hervé Le Louet
From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisham S. Aljadhey
From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France
PharmD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 36 no. 7 821-828
DOI 
https://doi.org/10.15537/smj.2015.7.11751
PubMed 
26108586

Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Received March 18, 2015
  • Accepted May 4, 2015
  • Published online July 1, 2015.

Copyright & Usage 
Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

  1. Thamir M. Alshammari, MSc, PhD⇑,
  2. Wa’ad H. Al-Kathiri, BSc, MSc,
  3. Hervé Le Louet, MD, PhD and
  4. Hisham S. Aljadhey, PharmD, PhD
  1. From the Department of Clinical Pharmacy (Alshammari), College of Pharmacy, University of Hail, Hail, the Medication Safety Research Chair (Alshammari, Aljadhey), College of Pharmacy, King Saud University, the Department of Clinical Pharmacy (Al-Kathiri, Aljadhey), College of Pharmacy, King Saud University, the Pharmacy Service (Al-Kathiri, Aljadhey), King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia, and the Pharmacovigilance Department (Le Louet), Henri Mondor University Hospital (AP-HP), Créteil, France
  1. Address correspondence and reprint request to: Dr. Thamir M. Alshammari, Department of Clinical Pharmacy, College of Pharmacy, University of Hail, PO Box 6166, Hail 81442, Kingdom of Saudi Arabia. E-mail: thamer.alshammary{at}gmail.com
View Full Text

Cited By...

  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia
    Ahmed Y Aldryhim, Abdulrahman Alomair, Meshari Alqhtani, Mansour A. Mahmoud, Thamir M Alshammari, Lisa G Pont, Khalid M Kamal, Hisham Aljadhey, Alemayehu B Mekonnen, Monira Alwhaibi, Bander Balkhi, Tariq M Alhawassi
    Expert Opinion on Drug Safety 2019 18 8
  • Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016
    Ibrahim A. Oreagba, Kazeem A. Oshikoya, Comfort Ogar, Abiodun O. Adefurin, Ali Ibrahim, Olufunsho Awodele, Yetunde Oni
    Pharmacology Research & Perspectives 2017 5 2
  • First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports
    Ingrid Oosterhuis, Leàn Rolfes, Corine Ekhart, Annemarie Muller-Hansma, Linda Härmark
    Expert Opinion on Drug Safety 2018 17 2
  • Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017
    Kazeem Adeola Oshikoya, Ibrahim Abayomi Ogunyinka, Comfort Kunak Ogar, Abiodun Abiola, Ali Ibrahim, Ibrahim Adekunle Oreagba
    Therapeutic Advances in Drug Safety 2020 11
  • National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia
    Rasha A. Almubark, Rawabi H. Aljadani, Amani S. Alqahtani, Thamir M. Alshammari, Nasser F. BinDhim
    Drugs - Real World Outcomes 2020 7 2
  • Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
    Olufunsho Awodele, Rebecca Aliu, Ibrahim Ali, Yetunde Oni, Christianah Mojisola Adeyeye
    Pharmacology Research & Perspectives 2018 6 5
  • The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study
    Khalidah A. Alenzi, Najah S. Alanazi, Mohammed Almalki, Homoud alomrani, Fahad O. Alatawi
    Saudi Pharmaceutical Journal 2022 30 6
  • The comparative assessment of awareness, perspective, and basic practice skills about the Saudi pharmacovigilance system among students of different health-care professionals of a Saudi Female University
    Asmatanzeem Bepari, Rasha Assad Assiri, Maya Abdullah AlYahya, Shaden Jamaan AlGhamdi, Amal Mohammed AlGhamdi, Afrah Asaad AlOnazi
    Saudi Pharmaceutical Journal 2020 28 7
  • The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®
    Mafora F. Matlala, Martha S. Lubbe, Hanlie Steyn
    African Journal of Primary Health Care & Family Medicine 2023 15 1
  • A Systematic Scoping Review of the State of Pharmacovigilance and Governance in the MENA Region: Challenges and Opportunities
    Abeer Abdullah Hamid, Mohamed Izham Mohamed Ibrahim
    Pharmaceutical Medicine 2017 31 6
  • Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators
    Ebtihal Al-Shareef, Lateef M. Khan, Mohammed Alsieni, Shahid Karim, Fatemah O. Kamel, Huda M. Alkreathy, Duaa A. Bafail, Ibrahim M. Ibrahim, Abdulhadi S. Burzangi, Mohammed A. Bazuhair
    Healthcare 2023 11 5
  • Pharmacovigilance and outcomes: experience from Saudi Arabia narrative review
    Thamir M. Alshammari
    Expert Review of Pharmacoeconomics & Outcomes Research 2025 25 1
  • Antibiotics-Related Adverse Drug Reaction in a Tertiary Hospital in Saudi Arabia: A Cohort, Retrospective Study
    Hanan Ahmed Bakri, Abdulaziz A Jaly
    Cureus 2023
  • Evaluation of Elective Posting on Adverse Drug Reaction and Pharmacovigilance under Competency-based Medical Education Curriculum among Undergraduates: A New Step in Medical Education
    Sandeep Prakash Narwane, Palak Ashokkumar Agrawal, Varsha Narsingrao Mahavarakar
    Journal of Datta Meghe Institute of Medical Sciences University 2024 19 2
  • Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017
    H Steyn
    South African Medical Journal 2023
  • Retrospective Assessment of the Reporting of Adverse Drug Reactions in a Malaysian Clinical Training Center
    Ramadan M. Elkalmi, Mohamed Hassan Elnaem, Nurmisaliza Mohd Sapar, Ali Blebil
    Journal of Pharmacy and Bioallied Sciences 2021 13 3
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 36 (7)
Saudi Medical Journal
Vol. 36, Issue 7
1 Jul 2015
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
Thamir M. Alshammari, Wa’ad H. Al-Kathiri, Hervé Le Louet, Hisham S. Aljadhey
Saudi Medical Journal Jul 2015, 36 (7) 821-828; DOI: 10.15537/smj.2015.7.11751

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
Thamir M. Alshammari, Wa’ad H. Al-Kathiri, Hervé Le Louet, Hisham S. Aljadhey
Saudi Medical Journal Jul 2015, 36 (7) 821-828; DOI: 10.15537/smj.2015.7.11751
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia
  • Google Scholar

More in this TOC Section

  • Psychological stress and its association with bronchial asthma in Saudi Arabia
  • The factors affecting comfort and the comfort levels of patients hospitalized in the coronary intensive care unit
  • Exploring communication challenges with children and parents among pharmacists in Saudi Arabia
Show more Original Article

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire